Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor‐β‐induced expression in urothelial carcinoma-Reference-Cited by-同舟云学术

Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor‐β‐induced expression in urothelial carcinoma

Published:2018-02-20 Issue:4 Volume:109 Page:980-987
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shang Donghao¹^ORCID,Song Bo²,Liu Yuting³^ORCID

Affiliation:

1. Department of Urology Friendship Hospital Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation Capital Medical University Beijing China

2. Department of Urology Beijing Luhe Hospital Capital Medical University Beijing China

3. Department of Pathology Capital Medical University Beijing China

Funder

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13403

Reference41 articles.

1. Diagnosis and treatment of bladder cancer;Sharma S;Am Fam Physician,2009